Substance P (SP) and neurokinin 1 receptor (NK1R) are new targets for the treatment of chronic pruritus
British Journal of Dermatology Apr 27, 2019
Stander S, et al. - The pathogenesis of chronic pruritus, centering the role of substance P (SP) and neurokinin 1 receptor (NK1R) in itch signaling was estimated to illustrate NK1R antagonism as a likely approach for the treatment of chronic pruritus. Investigators observed NK1R expression in the central nervous system and on multiple cell types, involved in the initiation and transmission of itch. Disruption of NK1R antagonism in itch signaling reduced the itch and acted as a potential treatment of chronic pruritus across multiple diseases. It was also noted that SP and NK1R were overexpressed across multiple chronic itch-inducing conditions.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries